PAX2 and renal cell carcinoma: PAX2 protein expression has been associated with 81-95% of CC-RCCs [56, 57], and we have also shown that in vivo tumorigenicity of RCC cells is reduced following siRNA-mediated knockdown of PAX2 expression [58].